ACLARION, INC. Operating Leases, Income Statement, Sublease Revenue
ACLARION, INC. (ACON) reported Operating Leases, Income Statement, Sublease Revenue of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue · last filed 2024-03-28
- ACLARION, INC. operating leases, income statement, sublease revenue for the quarter ending 2023-12-31 was $0.00.
- ACLARION, INC. operating leases, income statement, sublease revenue for the quarter ending 2023-09-30 was $0.00.
- ACLARION, INC. operating leases, income statement, sublease revenue for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. operating leases, income statement, sublease revenue for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- ACLARION, INC. operating leases, income statement, sublease revenue for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ACLARION, INC. operating leases, income statement, sublease revenue for fiscal 2022 was $26.34K.
| Period end | Operating Leases, Income Statement, Sublease Revenue 3 month | Operating Leases, Income Statement, Sublease Revenue 6 month | Operating Leases, Income Statement, Sublease Revenue 9 month | Operating Leases, Income Statement, Sublease Revenue 9 month as first filed | Operating Leases, Income Statement, Sublease Revenue 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25 | $0.00 10-Q · filed 2023-08-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-07-03 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $13.17K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $13.17K derived: sum of 3 quarters · filed 2024-03-28 | $26.34K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $13.17K derived: sum of 2 quarters · filed 2023-11-14 | $26.34K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $13.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-25 | $26.34K 10-Q · filed 2023-08-25 | |||
| 2022-03-31 | $13.17K 10-Q · filed 2023-07-03 | ||||
| 2021-09-30 | $48.40K 10-K/A · filed 2023-06-12 | $25.14K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |